Clinical Trial Update: A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

View source ↗

Summary

This completed clinical trial evaluated adults with hereditary angioedema who are currently receiving icatibant at home.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Firazyr (icatibant)

Snippet

Sponsor: Takeda | Conditions: Hereditary Angioedema (HAE) | Status: COMPLETED